Shell (LON: SHEL) announces up to $2B impairment after selling its Singapore refinery and halting Rotterdam biofuel plant construction. Expect a total post-tax impairment of $1.2B-$1.8B reflected in Q2 results on August 1st. Monitor SHEL stock for strategic impacts.